[Federal Register Volume 59, Number 137 (Tuesday, July 19, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-17526]


[[Page Unknown]]

[Federal Register: July 19, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE
 

Manufacturer of Controlled Substances; Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 13, 1994, Applied Science 
Labs, Division of Alltech Associates, Inc., 2701 Carolean Industrial 
Drive, P.O. Box 440, State College, Pennsylvania 16801, made 
application to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                           Drug                               Schedule  
------------------------------------------------------------------------
Methcathinone (1237)......................................  I           
N-Ethylamphetamine (1475).................................  I           
N,N-Dimethylamphetamine (1480)............................  I           
4-Methylaminorex (cis isomer) (1590)......................  I           
Lysergic acid diethylamide (7315).........................  I           
Tetrahydrocannabinols (7370)..............................  I           
Mescaline (7381)..........................................  I           
3,4-Methylenedioxyamphetamine (7400)......................  I           
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)............  I           
3,4-Methylenedioxy-N-ethylamphetamine (7404)..............  I           
3,4-Methylenedioxymethamphetamine (7405)..................  I           
Psilocybin (7437).........................................  I           
Psilocyn (7438)...........................................  I           
N-Ethyl-1-phenylcyclohexylamine (7455)....................  I           
1-(1-Phenylcyclohexyl)pyrrolidine (7458)..................  I           
1-[1-(2-Thienyl)cyclo-....................................  I           
hexyl]piperidine (7470)...................................              
Dihydromorphine (9145)....................................  I           
Heroin (9200).............................................  I           
Normorphine (9313)........................................  I           
Amphetamine (1100)........................................  II          
Methamphetamine (11050....................................  II          
1-Phenylcyclohexylamine (7460)............................  II          
Phencyclidine (7471)......................................  II          
Phenylacetone (8501)......................................  II          
1-Piperidinocyclohexanecarbonitrile (8603)................  II          
Cocaine (9041)............................................  II          
Codeine (9050)............................................  II          
Dihydrocodeine (9120).....................................  II          
Benzoylecgonine (9180)....................................  II          
Morphine (9300)...........................................  II          
Oxymorphone (9652)........................................  II          
Alfentanil (9737).........................................  II          
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of these controlled 
substances for reference standards.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application and may also file a written 
request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
the form prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, DC 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than August 18, 1994.

    Dated: July 11, 1994.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control Drug 
Enforcement Administration.
[FR Doc. 94-17526 Filed 7-18-94; 8:45 am]
BILLING CODE 4410-09-M